Form 4 for DGX Quest Diagnostics
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001022079-23-000070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-08 | 2023-03-06 | DGX | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $147.86 | +8,595 | 47.1K | +22% | +$1.27M | |
| 2023-03-08 | 2023-03-07 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $140.55 | -4,754 | 38.5K | -11% | -$668.2K | |
| 2023-03-08 | 2023-03-06 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $147.86 | -3,841 | 43.3K | -8% | -$567.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-06 | A | A | 8,595 | $147.86 | 47,122 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-07 | S | D | 4,754 | $140.55 | 38,527 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-06 | F | D | 3,841 | $147.86 | 43,281 | D | — | — |